These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17298224

  • 1. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
    Frank J, Poblete-Gutiérrez P, Weiskirchen R, Gressner O, Merk HF, Lammert F.
    Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
    [Abstract] [Full Text] [Related]

  • 2. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
    Tannapfel A, Stölzel U, Köstler E, Melz S, Richter M, Keim V, Schuppan D, Wittekind C.
    Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
    [Abstract] [Full Text] [Related]

  • 3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, Blanc F, Guilhou JJ.
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A, Celis R, Ozalla MD, Bruguera M, Herrero C, Ercilla MG.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [Abstract] [Full Text] [Related]

  • 5. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C, Halimi G, Ouzan D, Halfon P, Ortonne JP, Lacour JP.
    Dermatology; 2003 Nov; 206(3):212-6. PubMed ID: 12673077
    [Abstract] [Full Text] [Related]

  • 6. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J, Andant C, Gouya L, Malonova E, Grandchamp B, Martásek P, Deybac JC, Puy H.
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M, de Salamanca RE, Morales P, Martínez-Laso J, Fontanellas A, Castro MJ, Rojo R, Moscoso J, Zamora J, Serrano-Vela JI, Arnaiz-Villena A.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B, Chiaverini C, Dali-Youcef N, Schmitt M, Grima M, Hirth C, Lacour JP, Chosidow O.
    Dermatology; 2009 Mar; 218(1):15-21. PubMed ID: 19001803
    [Abstract] [Full Text] [Related]

  • 13. Iron overload in porphyria cutanea tarda.
    Sampietro M, Fiorelli G, Fargion S.
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [Abstract] [Full Text] [Related]

  • 14. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K, Drage LA, Brandhagen DJ, Pittelkow MR.
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C, Bergamo D, Barbieri S, Timbaldi M, Thea A, Martina G, Damiani D, Fenoglio R, Donati-Marella B, Priolo G.
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [Abstract] [Full Text] [Related]

  • 16. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ, Corrigall AV, Hancock V, Kannemeyer J, Kirsch RE, Meissner PN.
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L, Zd'árský E, Dandová S, Michalíková H, Cerná M, Cimburová M.
    Cas Lek Cesk; 2000 Nov 22; 139(23):728-30. PubMed ID: 11191743
    [Abstract] [Full Text] [Related]

  • 19. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM, Nakhle MC, Abrantes-Lemos CP, Cançado EL, Reis VM.
    An Bras Dermatol; 2013 Nov 22; 88(4):530-40. PubMed ID: 24068123
    [Abstract] [Full Text] [Related]

  • 20. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW.
    Hepatology; 1998 Jun 22; 27(6):1661-9. PubMed ID: 9620340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.